Christopher Brett Primiano - Net Worth and Insider Trading
Christopher Brett Primiano Net Worth
The estimated net worth of Christopher Brett Primiano is at least $4,794 dollars as of 2024-04-26. Christopher Brett Primiano is the EVP, CBO, GC & Secretary of Karyopharm Therapeutics Inc and owns about 4,523 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $4,794. Details can be seen in Christopher Brett Primiano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Brett Primiano has not made any transactions after 2020-12-01 and currently still holds the listed stock(s).
Transaction Summary of Christopher Brett Primiano
Christopher Brett Primiano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Brett Primiano owns 2 companies in total, including Karyopharm Therapeutics Inc (KPTI) , and Aura Biosciences Inc (AURA) .
Click here to see the complete history of Christopher Brett Primiano’s form 4 insider trades.
Insider Ownership Summary of Christopher Brett Primiano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2020-12-01 | VP & Gen Counsel & Secretary |
| AURA | Aura Biosciences Inc | 2021-10-28 | Chief Business Officer |
Christopher Brett Primiano Latest Holdings Summary
Christopher Brett Primiano currently owns a total of 1 stock. Christopher Brett Primiano owns 4,523 shares of Karyopharm Therapeutics Inc (KPTI) as of December 1, 2020, with a value of $4,794.
Latest Holdings of Christopher Brett Primiano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2020-12-01 | 4,523 | 1.06 | 4,794 |
Holding Weightings of Christopher Brett Primiano
Christopher Brett Primiano Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Brett Primiano has made a total of 9 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 137,061 shares on December 1, 2020, which brought Christopher Brett Primiano around $2 Million.
Insider Trading History of Christopher Brett Primiano
- 1
Christopher Brett Primiano Trading Performance
Christopher Brett Primiano Ownership Network
Ownership Network List of Christopher Brett Primiano
Ownership Network Relation of Christopher Brett Primiano
Christopher Brett Primiano Owned Company Details
What does Karyopharm Therapeutics Inc do?
Who are the key executives at Karyopharm Therapeutics Inc?
Christopher Brett Primiano is the VP & Gen Counsel & Secretary of Karyopharm Therapeutics Inc. Other key executives at Karyopharm Therapeutics Inc include EVP & Chief Medical Officer Reshma Rangwala , director & President and CEO Richard A. Paulson , and EVP & CFO & Treasurer Michael Mason .
Karyopharm Therapeutics Inc (KPTI) Insider Trades Summary
Over the past 18 months, Christopher Brett Primiano made no insider transaction in Karyopharm Therapeutics Inc (KPTI). Other recent insider transactions involving Karyopharm Therapeutics Inc (KPTI) include a net sale of 199,037 shares made by Richard A. Paulson , a net sale of 66,291 shares made by Michael Mason , and a net sale of 47,442 shares made by Sohanya Roshan Cheng .
In summary, during the past 3 months, insiders sold 255,827 shares of Karyopharm Therapeutics Inc (KPTI) in total and bought 0 shares, with a net sale of 255,827 shares. During the past 18 months, 423,673 shares of Karyopharm Therapeutics Inc (KPTI) were sold and 41,140 shares were bought by its insiders, resulting in a net sale of 382,533 shares.
Karyopharm Therapeutics Inc (KPTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Karyopharm Therapeutics Inc Insider Transactions
Christopher Brett Primiano Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Brett Primiano. You might contact Christopher Brett Primiano via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton Ma 02459.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
